Date: 2018-10-08
Type of information: Nomination
Compound: member of the board of directors
Company: Cytosen Therapeutics (USA - TX)
Therapeutic area: Cancer - Oncology
Type agreement: nomination
Action mechanism:
Disease:
Details:
- • On October 8, 2018, CytoSen Therapeutics announced the appointment of Jason Wilson to the company’s board of directors. Mr. Wilson, who currently serves as the Chief Financial Officer of Reata Pharmaceuticals, brings more than 20 years of experience in corporate finance and life science operations to CytoSen’s Board.
- Mr. Wilson joined Reata in 2006, and has played a key role in helping to grow the company from a startup through its 2016 initial public offering. He currently leads corporate strategy, finance, accounting, treasury, human resources, business development, investor relations and information technology at Reata. Prior to joining Reata, he held positions as Vice President, Finance & Corporate Controller at Caris Diagnostics and Senior Manager in the health-sciences group at Ernst & Young LLP. Mr. Wilson holds a B.B.A. in Accounting from Henderson University, an M.B.A. from the University of Central Arkansas and is a CPA.
Financial terms:
Latest news:
Is general: Yes
